10 Sep Interview with Proactive Investors Posted at 20:54h in News by Rebecca James 0 Comments 0 Likes Managing Director, John Kelly speaks to Proactive about the broad applications for Atomo’s rapid blood-based tests at the ASX Small and Mid-Cap Conference. Tags: ASX, Atomo Diagnostics, Lateral Flow, Rapid Diagnostic Test
